Santen Pharmaceutical Co., Ltd. (TYO:4536)
1,421.00
-6.00 (-0.42%)
Apr 2, 2025, 3:30 PM JST
Santen Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 479,974 | 559,190 | 424,342 | 490,898 | 608,810 | 742,066 | Upgrade
|
Market Cap Growth | 8.00% | 31.78% | -13.56% | -19.37% | -17.96% | 12.77% | Upgrade
|
Enterprise Value | 401,306 | 476,424 | 362,459 | 422,435 | 555,406 | 661,036 | Upgrade
|
Last Close Price | 1427.00 | 1502.24 | 1080.06 | 1137.22 | 1380.10 | 1657.76 | Upgrade
|
PE Ratio | 18.44 | 21.00 | - | 18.04 | 89.19 | 31.42 | Upgrade
|
Forward PE | 14.21 | 17.09 | 25.03 | 16.26 | 21.32 | 20.43 | Upgrade
|
PS Ratio | 1.67 | 1.85 | 1.52 | 1.84 | 2.44 | 3.07 | Upgrade
|
PB Ratio | 1.72 | 1.83 | 1.45 | 1.46 | 1.98 | 2.45 | Upgrade
|
P/TBV Ratio | 2.70 | 2.52 | 2.15 | 2.37 | 3.13 | 4.06 | Upgrade
|
P/FCF Ratio | 10.39 | 8.83 | 21.36 | 17.11 | 17.56 | 21.75 | Upgrade
|
P/OCF Ratio | 10.00 | 7.70 | 11.42 | 10.66 | 15.69 | 18.58 | Upgrade
|
PEG Ratio | 1.35 | 2.79 | 2.79 | 2.79 | 3.56 | 3.88 | Upgrade
|
EV/Sales Ratio | 1.33 | 1.58 | 1.30 | 1.59 | 2.23 | 2.74 | Upgrade
|
EV/EBITDA Ratio | 6.20 | 6.77 | 6.90 | 7.98 | 7.90 | 11.71 | Upgrade
|
EV/EBIT Ratio | 8.62 | 9.13 | 10.27 | 11.78 | 10.38 | 16.58 | Upgrade
|
EV/FCF Ratio | 8.69 | 7.52 | 18.24 | 14.72 | 16.02 | 19.37 | Upgrade
|
Debt / Equity Ratio | - | 0.11 | 0.12 | 0.10 | 0.03 | 0.04 | Upgrade
|
Debt / EBITDA Ratio | - | 0.49 | 0.69 | 0.62 | 0.14 | 0.22 | Upgrade
|
Debt / FCF Ratio | - | 0.55 | 1.82 | 1.15 | 0.29 | 0.36 | Upgrade
|
Asset Turnover | 0.73 | 0.71 | 0.63 | 0.62 | 0.62 | 0.60 | Upgrade
|
Inventory Turnover | 2.67 | 2.99 | 2.95 | 2.79 | 2.56 | 2.69 | Upgrade
|
Quick Ratio | 1.87 | 2.00 | 1.85 | 1.91 | 2.02 | 2.64 | Upgrade
|
Current Ratio | 2.61 | 2.55 | 2.38 | 2.39 | 2.63 | 3.23 | Upgrade
|
Return on Equity (ROE) | 9.45% | 8.92% | -4.75% | 8.45% | 2.18% | 7.30% | Upgrade
|
Return on Assets (ROA) | 7.75% | 7.61% | 5.01% | 5.20% | 8.25% | 6.23% | Upgrade
|
Return on Capital (ROIC) | 11.02% | 9.74% | 6.31% | 6.53% | 10.58% | 8.15% | Upgrade
|
Return on Capital Employed (ROCE) | 16.00% | 15.20% | 10.60% | 9.90% | 16.50% | 11.70% | Upgrade
|
Earnings Yield | 5.73% | 4.76% | -3.52% | 5.54% | 1.12% | 3.18% | Upgrade
|
FCF Yield | 9.63% | 11.33% | 4.68% | 5.85% | 5.70% | 4.60% | Upgrade
|
Dividend Yield | 2.68% | 2.20% | 2.96% | 2.81% | 2.03% | 1.63% | Upgrade
|
Payout Ratio | 44.13% | 44.59% | - | 44.07% | 163.81% | 43.95% | Upgrade
|
Buyback Yield / Dilution | 4.34% | 4.98% | 3.26% | -0.02% | -0.03% | 1.75% | Upgrade
|
Total Shareholder Return | 7.02% | 7.17% | 6.22% | 2.80% | 2.00% | 3.38% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.